Hide This

FREEHER HealthToolkit

HER Health Toolkit

Sign up for EmpowHER updates and you'll receive our
FREE HER Health Toolkit

Menopause

Get Email Updates

Menopause Guide

Rosa Cabrera RN

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!

FDA Approves Non-Hormonal Treatment for Hot Flashes

By Stacy Lloyd HERWriter
 
Rate This
FDA Approves Non-Hormonal Treatment for Hot Flashes 0 5
non-hormonal hot flash treatment approved by FDA
MonkeyBusiness Images/PhotoSpin

The U.S. Food and Drug Administration just approved Brisdelle (paroxetine) for the treatment of hot flashes due to menopause. This is the first non-hormonal drug designed to treat hot flashes, one of the most bothersome symptoms of menopause.

According to a U.S. Food and Drug Administration (FDA) news release, paroxetine contains the selective serotonin reuptake inhibitor paroxetine mesylate.

The move was surprising because an advisory committee to the FDA voted 10 to 4 in March against approval, stated the New York Times (NYT).

The panel likely disapproved of the drug, Dr. Tara Shirazian, a gynecologist at Mount Sinai Hospital explained on "CBS This Morning," because the scientific data was likely not compelling enough.

However, Shirazian pointed out to CBS News, Brisdelle has been used for years among OB-GYNs for the off-label indication to treat symptomatic hot flashes. It has been prescribed as the antidepressant drug Paxil, but now, the new FDA-approved drug is a lower dosage.

Other FDA-approved products for hot flashes contain estrogen alone or estrogen plus a progestin, wrote WSJ.

Hormone therapy was once a standard treatment to replace the hormones the body no longer makes after menopause. But its use dropped after 2002, when a large clinical trial showed the therapy increased the risk of heart disease and breast cancer, said Reuters.

Around 75 percent of women experience hot flashes when they enter menopause. Some may suffer from them for years, wrote MNT.

Women in the Brisdelle clinical trials started with a median of about 10 hot flash episodes a day. NYT reported that after 12 weeks those who took the drug had a median of nearly six fewer hot flash episodes a day, compared with a reduction of four or five episodes a day for those receiving the placebo.

"There are a lot of women who can't use hormone replacement therapy, and we understand more and more about the issues related to estrogen and progesterone each day," Shirazian told CBS News.

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Improved

1768 Health

Changed

671 Lives

Saved

532 Lives
4 lives impacted in the last 24 hrs Learn More

Take Our Featured Health Poll

Do you have hot flashes due to menopause? :
View Results